CONSERVATIVE MANAGEMENT OF PARAVAGINAL HEMATOMA SECONDARY TO ANTERIOR PROLIFT SURGERY : A CASE REPORT H. BRAUN1, C. RONDINI 1, F. JORDAN 1, S. AROS 2, C. DESCOUVIERES 1, F. TRONCOSO 1; 1Departamento de Ginecología, Unidad de gestión clínica de la mujer y el recién nacido, Hosp. Padre Hurtado, Facultad de Med. Clínica Alemana – Univ. del Desarrollo, Santiago, Chile, 2Matrona de Uroginecologia, Departamento de Ginecología, Unidad de gestión clínica de la mujer y el recién nacido, Hosp. Padre Hurtado, Facultad de Med. Clínica Alemana – Univ. del Desarrollo, Santiago, Chile.
Objective: To report a case of conservative management of paravesical hematoma secondary to anterior Prolift. Background: Because up to one third of the patients operated of genital prolapse might require new surgery due to relapse, during the last years we have seen the development of new surgical techniques and prosthetic Kits that look for better results. Nevertheless, the popularity these have gained has also allowed us to witness the new complications related either to their use or to the learning curve of surgeons with less experience or of beginners in this type of surgery. Hematomas are infrequent, appearing in the different series with rates of about 1% frequency. Methods: BRL, 55 years old , POP stage 3 Ba. In November 2008 she was submitted to surgery for anterior Prolift which was performed with no major intraoperative complications , presenting hypogastric pain 5 hours postoperative time. An 8cm tumor was palpated upon physical examination. The abdominal and transvaginal ultrasonography showed a complex ultrasound image of 110 x 60 mm. Abdomen and pelvis CT scan revealed a left paravesical extraperitoneal hematoma of 12 x 7 x 5 cm that shifted the uterus and the bladder to the right . Conclusion: Extraperitoneal hematomas are an infrequent complication of the use of Kits for prolapse The patient evolved hemodynamically stable with hematocrit levels after 6 and 48 hours postoperative time of 31.2% and 32.1% respectively (preoperative hematocrit level of 41%). She was treated with analgesics and antibiotics (Ceftriaxone 1gr / d + Metronidazol 500 mg ev td for 48 hrs and then Ciprofloxacin 500mg qd + Metrodinazol 500 mg td until completing 14 days). The patient was discharged from hospital in good condition the fourth postoperative day for ambulatory treatment and control. A slow but sustained decrease both of the size of the hematoma and of the pain was observed in the ambulatory follow-up. So far (3 months follow up) no signs of infection, erosion of the mesh or relapse have been observed. repair surgery with prosthetic material. Nevertheless, they must be considered in the differential diagnosis of patients that evolve with excessive pain, significant decrease of hematocrit levels or hemodynamic instability in early postoperative time. Conservative management with analgesics and antibiotic prophylaxis seems to be a safe alternative in hemodynamically stable patients and it seems not to increase the risk of infection, erosion or relapse.
Equine Prohibited Substances List This is the Equine Prohibited Substances List that was sent out to all NFs on 20 October. Neither this List nor the Equine Anti-Doping and Controlled Medication Regulations (EADCMR) are in current usage and, following a Bureau resolution passed on 17 December 2009, they will come into effect on 5 April 2010. The existing list of FEI prohibited substances,